REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Grynumber Health (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Grynumber Health Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Grynumber Health is an enterprise based in Lithuania. Its main office is in Vilnius. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 09, 2014. It currently has a total number of 15 (2025) employees. From the latest financial highlights, UAB Grynumber Health reported a net sales revenue drop of 8.43% in 2024. UAB Grynumber Health’s net profit margin increased by 0.08% in 2024.

Headquarters
Menulio g. 11-101
Vilnius; Vilnius county; Postal Code: LT-04326

Contact Details: Purchase the UAB Grynumber Health report to view the information.

Website: https://grynumberhealth.com/

Basic Information
Total Employees:
Purchase the UAB Grynumber Health report to view the information.
Registered Capital:
Purchase the UAB Grynumber Health report to view the information.
Financial Auditors:
Purchase the UAB Grynumber Health report to view the information.
Incorporation Date:
July 09, 2014
Key Executives
Purchase this report to view the information.
Director
Subsidiaries
UAB Caerus Biotechnologies
Company Performance
Financial values in the chart are available after UAB Grynumber Health report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.43%
Total Operating Revenue
-8.43%
Net Profit/Loss for the Period
-7.39%
Total Equity
-0.58%
Net Profit Margin
0.08%
Return on Equity (ROE)
-1.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?